Bank Of Nova Scotia Novavax Inc Transaction History

Bank Of Nova Scotia

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$69.73 - $142.9 $3.33 Million - $6.83 Million	-47,783 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $2.71 Million - $4.38 Million	-20,117 Reduced 29.63%	47,783 $6.89 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $8.28 Million - $12.6 Million	46,588 Added 218.6%	67,900 $14.1 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $2.58 Million - $5.49 Million	21,312 New	21,312 $4.52 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.